WASHINGTON, Nov. 4 (TNSdock) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Natuzem from its Center for Drug Evaluation and Research:

* * *

Recipient: Natuzem, 201 General Guadalupe Victoria, 20000 Aguascalientes AGS, Mex. Mexico, natuzemags@gmail.com, natuzem@natuzem.com

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

WARNING LETTER